ation of the distribution network through which we sell our products, including wholesale drug distributors and the growth of large retail drug store chains; the loss of key senior management or scientific staff; adverse outcomes in our'/>/>SOURCE Warner Chilcott plcCopyright??2010 PR Newswire.All rights reserved0GOODPage: 1 2 3 Related medicine technology :1.